Why Biogen Stock Is Sinking This Week
The U.S. launch of Alzheimer’s disease drug Aduhelm is off to a sluggish start.
The U.S. launch of Alzheimer’s disease drug Aduhelm is off to a sluggish start.
These are three beaten up SPAC stocks that offer strong long-term growth potential—and can be had at prices below the key $10…
The UK’s Financial Reporting Council (FRC) has been working on an equivalent of the U.S. Sarbanes-Oxley Act (or SOX) for several…
Every investor in Logistics Development Group plc ( LON:LDG ) should be aware of the most powerful shareholder groups…
Welcome to Next Africa, a weekly newsletter of where the continent stands now — and where it’s going next.
Homebuilder Hovnanian Enterprises (NYSE: HOV), which has been consolidating since early June, traded higher Thursday on the heels…
The Lovesac Company (NASDAQ: LOVE) hit our radar over the last year and has done nothing but impress us in the time since. Not…
(Reuters) – 1/WANTED: PRIME MINISTER In the wide-open contest to be Japan’s next premier, hopefuls have until Friday to announce…
Economists said global supply-chain disruptions are making themselves felt in the UK economy, which was also hit by rising COVID-19…
At its Investor Day, Willis Towers Watson introduced the new CEO and laid out a 3-year plan for earnings and free cash flow….